Utility of 2-year Kidney Failure Risk Equation for advanced chronic kidney disease: analysis from the STOP-ACEi trial

Nephrol Dial Transplant. 2024 Apr 26;39(5):884-887. doi: 10.1093/ndt/gfad263.

Authors

Sunil Bhandari¹, Samir Mehta², Natalie Ives², Paul Cockwell³

Affiliations

¹ Department of Renal Medicine, Hull University Teaching Hospitals NHS Trust, and Hull York Medical School, East Yorkshire, UK.
² Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK.
³ Department of Renal Medicine, Queen Elizabeth Hospital, Birmingham, UK.

PMID: 38115669
DOI: 10.1093/ndt/gfad263

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Female
Glomerular Filtration Rate
Humans
Kidney Failure, Chronic* / complications
Kidney Failure, Chronic* / therapy
Male
Middle Aged
Prognosis
Risk Factors

Substances

Angiotensin-Converting Enzyme Inhibitors

Grants and funding